Literature DB >> 1836037

Effects of palm oil on cardiovascular risk.

Y H Chong1, T K Ng.   

Abstract

A major public health concern of affluent nations is the excessive consumption of dietary fats which are now closely linked to coronary heart disease. Against this scenario, the tropical oils and palm oil in particular, have been cast as major villains in the U.S.A., despite the fact that palm oil consumption there is negligible. The unsuspecting public may not realise that the call to avoid palm oil is nothing more than a trade ploy since in recent years palm oil has been very competitive and has gained a major share of the world's edible oils and fats market. Many also lose sight of the fact that, palm oil, like other edible oils and fats, is an important component of the diet. The allegation that palm oil consumption leads to raised blood cholesterol levels and is therefore atherogenic is without scientific foundation. Examination of the chemical and fatty acid composition of palm oil or its liquid fraction should convince most nutritionists that the oil has little cholesterol-raising potential. The rationale for these are: it is considered cholesterol free. its major saturated fatty acid, palmitic acid (16:0) has recently been shown to be neutral in its cholesterolaemic effect, particularly in situations where the LDL receptors have not been down-regulated by dietary means or through a genetic effect. palm oil contains negligible amounts (less than 1.5%) of the hypercholesterolemic saturated fatty acids, namely lauric acid (12:0) and myristic acid (14:0). it has moderately rich amounts of the hypocholesterolaemic, monounsaturated oleic acid (18:1, omega-9) and adequate amounts of linoleic acid. (18:2, omega-6). It contains minor components such as the vitamin E tocotrienols which are not only powerful antioxidants but are also natural inhibitors of cholesterol synthesis. Feeding experiments in various animal species and humans also do not support the allegation that palm oil is atherogenic. On the contrary, palm oil consumption reduces blood cholesterol in comparison with the traditional sources of saturated fats such as coconut oil, dairy and animal fats. In addition, palm oil consumption may raise HDL levels and reduce platelet aggregability. As with all nutrients, there is a need to obtain a balance of different fatty acids found in fats in edible oils and other food sources. There is no single ideal source of fat that answers to the recent American Heart Association's call to reflect a 1:1:1 ratio of saturated, monounsaturated and polyunsaturated fats in relation to the recommended dietary fat intake of 30% of calories or less.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1836037

Source DB:  PubMed          Journal:  Med J Malaysia        ISSN: 0300-5283


  6 in total

Review 1.  Palm oil and the heart: A review.

Authors:  Osaretin J Odia; Sandra Ofori; Omosivie Maduka
Journal:  World J Cardiol       Date:  2015-03-26

Review 2.  Palm oil: biochemical, physiological, nutritional, hematological, and toxicological aspects: a review.

Authors:  D O Edem
Journal:  Plant Foods Hum Nutr       Date:  2002       Impact factor: 3.921

Review 3.  Influence of palm oil (Elaesis guineensis) on health.

Authors:  P E Ebong; D U Owu; E U Isong
Journal:  Plant Foods Hum Nutr       Date:  1999       Impact factor: 3.921

Review 4.  Coconut oil and palm oil's role in nutrition, health and national development: A review.

Authors:  Laurene Boateng; Richard Ansong; William B Owusu; Matilda Steiner-Asiedu
Journal:  Ghana Med J       Date:  2016-09

5.  Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis.

Authors:  Laura Martínez; Sandra Torres; Anna Baulies; Cristina Alarcón-Vila; Montserrat Elena; Gemma Fabriàs; Josefina Casas; Joan Caballeria; Jose C Fernandez-Checa; Carmen García-Ruiz
Journal:  Oncotarget       Date:  2015-12-08

Review 6.  Systematic review of palm oil consumption and the risk of cardiovascular disease.

Authors:  Sophia Rasheeqa Ismail; Siti Khuzaimah Maarof; Syazwani Siedar Ali; Azizan Ali
Journal:  PLoS One       Date:  2018-02-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.